不同慢性病患者群体的疲劳:患者的经验和需求
Eline Schade van Westrum1, Ellen K Hoogeveen1,2,3, Birit F P Broekman4
1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Clinical kidney journal
|July 2, 2025
概括
慢性病 (CKD) 患者经历显著的疲劳,影响所有人群的日常生活. 解决这个问题需要更好的支持,讨论,以及在日常护理中的多学科症状管理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 患者报告的结果
- 慢性疾病管理 慢性疾病管理
背景情况:
- 疲劳是慢性病 (CKD) 的普遍和负担重重的症状.
- 以前的研究主要集中在透析患者使用定性方法.
- 需要对各种CKD人群的疲劳有全面的了解.
研究的目的:
- 探索经历过的疲劳负担,它对日常生活的影响,以及各种CKD人群中感知到的原因.
- 调查CKD患者对疲劳的经验和需要的支持,讨论和治疗.
主要方法:
- 一项全国性的调查与荷兰病患者协会共同创建.
- 用描述性统计数据来分析数据.
- 结果按CKD患者群体 (透析前,透析后,移植后),性别和年龄分层.
主要成果:
- 在所有CKD人群 (n=414) 中报告了高疲劳负担,其中94.7%的人经历了疲劳.
- 疲劳是86.3%的患者的前三大负担性症状,原因多因素.
- 许多患者 (32.1%) 很少与医生讨论疲劳问题,67.8% 没有接受治疗,58.6% 认为现有的治疗方法不足. 较年轻的患者和女性报告了更大的限制和社会支持不足.
结论:
- 在所有CKD患者群体中存在显著的疲劳负担和不足的支持.
- 在科护理中,对疲劳的结构性测量和讨论至关重要.
- 需要加强社会支持和以患者为中心的多学科症状管理,以解决未满足的患者需求.
相关概念视频
Chronic Kidney Disease IV: Nursing Management
60
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
60
Chronic Kidney Disease II: Clinical Manifestations
104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
Chronic Kidney Disease III: Interprofessional Care
82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
Chronic Kidney Disease I: Introduction
76
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
76
Acute Kidney Injury VI: Nursing Management
67
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
67
Heart Failure VI: Adjunct Therapies
38
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
38


